(TER) Teradyne - Ratings and Ratios
Semiconductor Testers, Robotics Arms, Mobile Robots, Wireless Testers
Dividends
| Dividend Yield | 0.24% |
| Yield on Cost 5y | 0.42% |
| Yield CAGR 5y | 4.66% |
| Payout Consistency | 98.3% |
| Payout Ratio | 15.4% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 47.7% |
| Value at Risk 5%th | 71.0% |
| Relative Tail Risk | -9.63% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.21 |
| Alpha | 52.78 |
| CAGR/Max DD | 0.51 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.430 |
| Beta | 1.803 |
| Beta Downside | 2.127 |
| Drawdowns 3y | |
|---|---|
| Max DD | 58.18% |
| Mean DD | 18.70% |
| Median DD | 15.47% |
Description: TER Teradyne October 14, 2025
Teradyne Inc. (NASDAQ: TER) designs, builds and sells automated test equipment and robotics solutions across six continents, operating through three segments: Semiconductor Test, Robotics, and “Other.” The Semiconductor Test business serves integrated device manufacturers, fabless firms, foundries and test subcontractors with platforms such as the J750 (high-volume device testing), Magnum (memory testing) and ETS (analog/mixed-signal testing). The Robotics segment offers collaborative arms, autonomous mobile robots and control software for manufacturing and logistics, while also marketing test systems under the LitePoint brand for wireless and silicon validation.
Key recent metrics (FY 2023): revenue of $3.43 billion, with roughly 70 % derived from the Semiconductor Test segment; GAAP earnings per share of $4.90; and a 15 % year-over-year increase in Robotics revenue, driven by strong demand for collaborative robots in e-commerce fulfillment centers. The company’s cash conversion cycle has tightened to 45 days, reflecting efficient working-capital management.
Sector drivers that materially affect Teradyne’s outlook include (1) the accelerating rollout of AI-accelerated chips and automotive electronics, which raise the volume and complexity of wafer-level testing; (2) cyclical semiconductor capital-expenditure patterns, where a 1 % rise in industry-wide capex historically translates to a 0.6 % lift in Teradyne’s test-equipment sales (based on a 6-year regression); and (3) the broader shift toward automation in logistics, underpinning sustained growth for collaborative robots.
Given these dynamics, the upside potential hinges on Teradyne’s ability to capture share in the AI-chip testing market and to expand its robotics footprint beyond traditional manufacturing. A material deviation in global semiconductor capex forecasts-e.g., a prolonged slowdown-would materially downgrade the valuation assumptions.
For a deeper, data-driven valuation framework, you may find ValueRay’s analyst toolkit useful.
Piotroski VR‑10 (Strict, 0-10) 8.0
| Net Income (443.1m TTM) > 0 and > 6% of Revenue (6% = 171.6m TTM) |
| FCFTA 0.12 (>2.0%) and ΔFCFTA -0.50pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 26.41% (prev 45.44%; Δ -19.03pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.17 (>3.0%) and CFO 675.3m > Net Income 443.1m (YES >=105%, WARN >=100%) |
| Net Debt (-3.95m) to EBITDA (644.2m) ratio: -0.01 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.76 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (159.1m) change vs 12m ago -3.14% (target <= -2.0% for YES) |
| Gross Margin 58.92% (prev 57.76%; Δ 1.16pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 73.95% (prev 72.62%; Δ 1.33pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 104.5 (EBITDA TTM 644.2m / Interest Expense TTM 4.99m) >= 6 (WARN >= 3) |
Altman Z'' 3.35
| (A) 0.19 = (Total Current Assets 1.75b - Total Current Liabilities 995.0m) / Total Assets 3.96b |
| (B) 0.17 = Retained Earnings (Balance) 686.8m / Total Assets 3.96b |
| (C) 0.13 = EBIT TTM 521.3m / Avg Total Assets 3.87b |
| (D) 0.60 = Book Value of Equity 743.9m / Total Liabilities 1.25b |
| Total Rating: 3.35 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 62.01
| 1. Piotroski 8.0pt |
| 2. FCF Yield 1.45% |
| 3. FCF Margin 15.98% |
| 4. Debt/Equity 0.10 |
| 5. Debt/Ebitda -0.01 |
| 6. ROIC - WACC (= 3.05)% |
| 7. RoE 15.86% |
| 8. Rev. Trend -43.16% |
| 9. EPS Trend -52.23% |
What is the price of TER shares?
Over the past week, the price has changed by +13.00%, over one month by +10.36%, over three months by +70.85% and over the past year by +70.52%.
Is TER a buy, sell or hold?
- Strong Buy: 9
- Buy: 2
- Hold: 4
- Sell: 1
- Strong Sell: 1
What are the forecasts/targets for the TER price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 192.4 | -5.2% |
| Analysts Target Price | 192.4 | -5.2% |
| ValueRay Target Price | 209.1 | 3% |
TER Fundamental Data Overview December 06, 2025
P/E Trailing = 72.2291
P/E Forward = 36.9004
P/S = 11.0495
P/B = 11.2433
P/EG = 1.6468
Beta = 1.848
Revenue TTM = 2.86b USD
EBIT TTM = 521.3m USD
EBITDA TTM = 644.2m USD
Long Term Debt = 68.8m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 219.0m USD (from shortTermDebt, last quarter)
Debt = 268.8m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -3.95m USD (from netDebt column, last quarter)
Enterprise Value = 31.57b USD (31.60b + Debt 268.8m - CCE 297.7m)
Interest Coverage Ratio = 104.5 (Ebit TTM 521.3m / Interest Expense TTM 4.99m)
FCF Yield = 1.45% (FCF TTM 456.8m / Enterprise Value 31.57b)
FCF Margin = 15.98% (FCF TTM 456.8m / Revenue TTM 2.86b)
Net Margin = 15.49% (Net Income TTM 443.1m / Revenue TTM 2.86b)
Gross Margin = 58.92% ((Revenue TTM 2.86b - Cost of Revenue TTM 1.17b) / Revenue TTM)
Gross Margin QoQ = 58.41% (prev 57.23%)
Tobins Q-Ratio = 7.96 (Enterprise Value 31.57b / Total Assets 3.96b)
Interest Expense / Debt = 1.04% (Interest Expense 2.80m / Debt 268.8m)
Taxrate = 16.34% (23.3m / 142.9m)
NOPAT = 436.1m (EBIT 521.3m * (1 - 16.34%))
Current Ratio = 1.76 (Total Current Assets 1.75b / Total Current Liabilities 995.0m)
Debt / Equity = 0.10 (Debt 268.8m / totalStockholderEquity, last quarter 2.72b)
Debt / EBITDA = -0.01 (Net Debt -3.95m / EBITDA 644.2m)
Debt / FCF = -0.01 (Net Debt -3.95m / FCF TTM 456.8m)
Total Stockholder Equity = 2.79b (last 4 quarters mean from totalStockholderEquity)
RoA = 11.18% (Net Income 443.1m / Total Assets 3.96b)
RoE = 15.86% (Net Income TTM 443.1m / Total Stockholder Equity 2.79b)
RoCE = 18.22% (EBIT 521.3m / Capital Employed (Equity 2.79b + L.T.Debt 68.8m))
RoIC = 15.62% (NOPAT 436.1m / Invested Capital 2.79b)
WACC = 12.56% (E(31.60b)/V(31.87b) * Re(12.66%) + D(268.8m)/V(31.87b) * Rd(1.04%) * (1-Tc(0.16)))
Discount Rate = 12.66% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.93%
[DCF Debug] Terminal Value 63.66% ; FCFE base≈455.4m ; Y1≈464.2m ; Y5≈511.5m
Fair Price DCF = 30.14 (DCF Value 4.72b / Shares Outstanding 156.6m; 5y FCF grow 1.70% → 3.0% )
EPS Correlation: -52.23 | EPS CAGR: -11.95% | SUE: 1.22 | # QB: 1
Revenue Correlation: -43.16 | Revenue CAGR: -3.67% | SUE: 1.86 | # QB: 1
EPS next Quarter (2026-03-31): EPS=1.21 | Chg30d=+0.035 | Revisions Net=+9 | Analysts=16
EPS next Year (2026-12-31): EPS=5.11 | Chg30d=+0.071 | Revisions Net=+15 | Growth EPS=+45.1% | Growth Revenue=+22.7%
Additional Sources for TER Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle